Cargando…

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells

Detalles Bibliográficos
Autores principales:	Delaporte, M, Holl, V, Decoville, T, Penichon, J, Moog, C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767967/ http://dx.doi.org/10.1186/1742-4690-6-S3-P64

Ejemplares similares

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
por: Lederle, A, et al.
Publicado: (2009)

P11-16. Transfer of HIV-1 from Langerhans and interstitial dendritic cells to T lymphocytes: protection mediated by antibodies?
por: Peressin, M, et al.
Publicado: (2009)

P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes
por: Xu, K, et al.
Publicado: (2009)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production
por: Lederle, Alexandre, et al.
Publicado: (2014)

Using impedance-based approaches for measuring cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC)
por: Lamarche, Brandon, et al.
Publicado: (2015)

P10-07. Extremely rapid degranulation of NK cells activated by HIV-specific antibody dependent cellular cytotoxicity
por: Chung, A, et al.
Publicado: (2009)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
por: Khanna, Vidhi, et al.
Publicado: (2021)

The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas
por: Rosario, Maximillian, et al.
Publicado: (2014)

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART)
por: Jensen, Sanne Skov, et al.
Publicado: (2015)

P04-44. Generation of antibody responses to HIV-1 membrane proximal external region (MPER) antigen
por: Holl, TM, et al.
Publicado: (2009)

P04.36. Abstract withdrawn from publication
Publicado: (2012)

P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody
por: Verkoczy, L, et al.
Publicado: (2009)

Antibody subclass skewing predicts enhanced ADCC activity in both natural infection and vaccination
por: Dugast, A, et al.
Publicado: (2012)

Reovirus activated NK cells show enhanced cetuximab mediated antibody-dependent cellular cytotoxicity against colorectal cancer cells
por: Zhao, Xing, et al.
Publicado: (2015)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
por: Mielke, Dieter, et al.
Publicado: (2019)

Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.
por: Pehamberger, H., et al.
Publicado: (1980)

Critical role for monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity
por: Kramski, M, et al.
Publicado: (2012)

P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
por: Xu, H, et al.
Publicado: (2009)

Ex-vivo expanded human NK cells mediate cytotoxicity and cytokine release against allogeneic cancer cell line by direct recognition and antibody directed cellular cytotoxicity: therapeutic potential use of NK cells for blood and solid tumors
por: Liacini, Abdelhamid, et al.
Publicado: (2014)

P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection
por: Bonsignori, M, et al.
Publicado: (2009)

Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC)
por: Jäpel, M., et al.
Publicado: (1994)

IFNγ-induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells
por: Concha-Benavente, Fernando, et al.
Publicado: (2014)

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection
por: Chen, W, et al.
Publicado: (2009)

Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses
por: Pollara, Justin, et al.
Publicado: (2013)

P04-33. Mechanisms of HIV-1 antibody mediated inhibition in Monomac-1 and MDM
por: Fischetti, L, et al.
Publicado: (2009)

γδT cells are ADCC effectors in elite HIV controllers
por: Poonia, Bhawna, et al.
Publicado: (2010)

Natural Killer cells present in gut mucosa as potential ADCC effector cells
por: Sips, M, et al.
Publicado: (2012)

P04-15. Prevalence of broadly neutralizing antibody responses during acute/early HIV infection
por: Mikell, I, et al.
Publicado: (2009)

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family
por: Bonsignori, M, et al.
Publicado: (2012)

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
por: Tang, Jennifer J.-J., et al.
Publicado: (2020)

P04-37. Kinetic and thermodynamic factors determine HIV-1 neutralizing potency of MPER-specific antibodies
por: Ruprecht, C, et al.
Publicado: (2009)

P04-40. Dissecting pre- and post-attachment activity of HIV-1 entry inhibitors and neutralizing antibodies
por: Berlinger, L, et al.
Publicado: (2009)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

P04-53 LB. Potent and broad HIV-specific neutralizing antibodies in infants are not associated with prevention of mother to infant HIV transmission
por: Lynch, J, et al.
Publicado: (2009)

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
por: Moog, C, et al.
Publicado: (2012)

High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19
por: Vietzen, Hannes, et al.
Publicado: (2022)

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
por: Iida, Shigeru, et al.
Publicado: (2009)

P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
por: Powell, RL, et al.
Publicado: (2009)

P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k2lqi0cgd5o303424v7omoh0lo